Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 604-609

  Schmidt, A M ^a,b   Imesch, P ^a   Fink, D ^a   Egger, H ^b  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^b General Hospital Neumarkt   (Germany)

Author keywords

Cervical cancer; Pelvic exenteration; Radical surgery; Survival

Indexed keywords

ADULT; AGED; ANASTOMOSIS INSUFFICIENCY; CANCER PATIENT; CONFERENCE PAPER; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; LAPAROTOMY; LUNG EMBOLISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PELVIS EXENTERATION; PELVIS LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; SEPSIS; SURGICAL MORTALITY; TREATMENT INDICATION; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84861188109     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.001     Document Type: Conference Paper

References (31)

1. A. Brunschwig Complete excision of pelvic viscera for advanced carcinoma Cancer 1 1948 177 183
2. E.M. Bricker Bladder substitution after pelvic evisceration Surg Clin North Am 30 5 1950 Oct 1511 1521
3. H.R. Butcher Jr., W.L. Sugg, C.A. McAfee, and E.M. Bricker Ileal conduit method of ureteral urinary diversion Ann Surg 156 1962 Oct 682 691
4. M. Höckel, and N. Dornhöfer Pelvic exenteration for gynaecological tumours: achievements and unanswered questions Lancet Oncol 7 10 2006 Oct 837 847
5. M. Höckel Pelvic recurrences of cervical cancer J Pelvic Surg 5 5 1999 255 266
6. R.E. Symmonds, J.H. Pratt, and M.J. Webb Exenterative operations: experience with 198 patients Am J Obstet Gynecol 121 7 1975 Apr 1 907 918
7. H.M. Shingleton, S.J. Soong, M.S. Gelder, K.D. Hatch, V.V. Baker, and J.M. Austin Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix Obstet Gynecol 73 6 1989 Jun 1027 1034
8. R.A. Lawhead, D.G. Clark, and D.H. Smith Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10 year review of thr Memorial Sloan-Kettering Cancer Center experience (1972-1981) Gynecol Oncol 33 3 1989 Jun 279 282
9. C.R. Stanhope, M.J. Webb, and K.C. Podratz Pelvic exenteration for recurrent cervical cancer Clin Obstet Gynecol 33 4 1990 Dec 897 909
10. A.S. Ketcham, P.J. Deckers, E.V. Sugarbaker, R.C. Hoye, L.B. Thomas, and R.R. Smith Pelvic exenteration for carcinoma of the uterine cervix. A 15-year experience Cancer 26 3 1970 Sep 513 521
11. P.J. Deckers, A.S. Ketcham, E.V. Sugarbaker, R.C. Hoye, and L.B. Thomas Pelvic exenteration for primary carcinoma of the uterine cervix Obstet Gynecol 37 5 1971 May 647 659
12. J.S. Berek, C. Howe, L.D. Lagasse, and N.F. Hacker Pelvic exenterattin for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA Gynecol Oncol 99 1 2005 Oct 153 159
13. C. Fotopoulou, U. Neumann, R. Kraetschell, J.C. Schefold, H. Weidemann, and W. Lichtenegger Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies J Surg Oncol 101 6 2010 May 1 507 512
14. M. Jurado, J.L. Alcazar, and R. Martinez-Monge Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? A twenty year experience Gynecol Oncol 116 1 2010 Jan 38 43 Epub 2009 Oct 29.
15. A. Maggioni, G. Roviglione, F. Landoni, V. Zanagnolo, M. Peiretti, and N. Colombo Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan Gynecol Oncol 114 1 2009 Jul 64 68 Epub 2009 May 2.
16. J.H. De Wilt, D.H. van Leeuwen, A. Logmans, C. Verhoef, W.J. Kirkels, and M. Vermaas Pelvic exenteration for primary and recurrent gynaecological malignancies Eur J Obstet Gynecol Reprod Biol 134 2 2007 Oct 243 248 Epub 2006 Sep 6.
17. S. Marnitz, C. Köhler, M. Müller, K. Behrens, K. Hasenbein, and A. Schneider Indications for primary and secondary exenterations in patients with cervical cancer Gynecol Oncol 103 3 2006 Dec 1023 1030 Epub 2006 Aug 4.
18. M.A. Teran-Porcayo, I. Zeichner-Gancz, R.A. del-Casillo, A. Beltran-Ortega, and G. Solorza-Luna Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico Med Oncol 23 2 2006 219 223
19. L. Ungar, L. Palfalvi, and Z. Novak Primary pelvic exenteration in cervical cancer patients Gynecol Oncol 111 2 Suppl 2008 Nov S9 S12 Epub 2008 Sep 5.
20. G.L. Goldberg, P. Sukumvanich, M.H. Einstein, H.O. Smith, P.S. Anderson, and A.L. Fields Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003) Gynecol Oncol 101 2 2006 May 261 268 Epub 2006 Jan 19.
21. F.N. Rutledge, J.P. Smith, J.T. Wharton, and A.G. O'Quinn Pelvic exenteration: analysis of 296 patients Am J Obstet Gynecol 129 8 1977 Dec 15 881 892
22. F.N. Rutledge, and V.B. McGuffee Pelvic exenteration: prognostic significance of regional lymph node metastasis Gynecol Oncol 26 3 1987 Mar 374 380
23. H. Rodriguez Cuevas, A. Torres, M. de la Garza, D. Hernandez, and L. Herrera Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases J Surg Oncol 38 2 1988 Jun 121 125 Review.
24. F. Numa, H. Ogata, Y. Suminami, N. Tsunga, Y. Nakamura, and H. Tamura Pelvic exenteration for the treatment of gynecological malignancies Arch Gynecol Obstet 259 3 1997 133 138
25. M.P. Hopkins, and G.W. Morley Prognostic factors in advanced stage squamous cell cancer of the cervix Cancer 72 8 1993 Oct 15 2389 2393
26. M. Franchi, and N. Donatello Pelvic exenteration in gynecologic oncology Rev Eur J Gynaecol Oncol. 15 6 1994 469 474 Review.
27. C.R. Stanhope, and R.E. Symmonds Palliative exenteration - what, when, and why? Am J Obstet Gynecol 152 1 1985 May 1 12 16
28. T.M. Pawlik, J.M. Skibber, and M.A. Rodriguez-Bigas Pelvic exenteration for advanced pelvic malignancies Ann Surg Oncol 13 5 2006 May 612 623 Epub 2006 Mar 17.
29. R.R. Million, F. Rutledge, and G.H. Fletcher Stage IV carcinoma of the cervix with bladder invasion Am J Obstet Gynecol 113 2 1972 May 15 239 246
30. H. Ito, N. Shigematsu, T. Kawada, A. Kubo, K. Isobe, and R. Hara Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy Gynecol Oncol 67 2 1997 Nov 154 161
31. F. Paton, M. Paulden, P. Saramango, A. Manca, K. Misso, and S. Palmer Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix Health Technol Assess 14 Suppl. 1 2010 May 55 62 Review.